Table 1.
Demographics of WSiMD participants
Subject | Age Decade | Sex | Race | Dx | Gene | Dose | Ambulatory |
01 | 4th | M | WNH | LGMD | ANO5 | 85 mg | Yes |
02 | 4th | M | WNH | LGMD | ANO5 | 65 mg | Yes |
03 | 5th | M | WNH | BMD | DMD | 60 mg | No |
04 | 3rd | F | WH | LGMD | CAPN3 | 55 mg | Yes |
05 | 6th | F | WNH | LGMD | FKRP | 55 mg | No |
06 | 3rd | F | WNH | LGMD | SGCG | 50 mg | No |
07 | 3rd | M | WNH | LGMD | FKRP | 55 mg | No |
08 | 5th | M | SAI | LGMD | DYSF | 55 mg | No |
09 | 4th | F | WH | LGMD | DYSF | 65 mg | Yes |
10 | 5th | M | AA | LGMD | DYSF | 60 mg | No |
11 | 3rd | F | WH | LGMD | CAPN3 | 70 mg | Yes |
12 | 5th | M | WNH | LGMD | CAPN3 | 60 mg | No |
13 | 3rd | M | WNH | LGMD | CAPN3 | 45 mg | Yes |
14 | 7th | M | WH | LGMD | ANO5 | 80 mg | Yes |
15 | 5th | M | WNH | LGMD | CAPN3 | 65 mg | Yes |
16 | 3rd | M | WNH | LGMD | TTN | 70 mg | No |
17 | 5th | M | WNH | LGMD | CAPN3 | 70 mg | Yes |
18 | 2nd | M | WNH | LGMD | CAPN3 | 45 mg | Yes |
19 | 3rd | F | WNH | LGMD | CAPN3 | 60 mg | Yes |
20 | 3rd | F | WNH | LGMD | FKRP | 60 mg | Yes |
WNH: White Non-Hispanic. WH: White Hispanic. SAI: South Asian Indian. AA: African American.